Posts

Kura spins out Lilly-backed Caspian Therapeutics with $50M for next-gen diabetes therapy

on

Beyond GLP-1s, obesity-drug competition shifts to preclinical science

on

Moonwalk raises $70 million to develop fat-targeted siRNA obesity therapy

on

Pharvaris stock jumps after pivotal Phase 3 success in hereditary angioedema

on

Amgen’s Imdelltra lands major new lung cancer victory

on

Inhibitor Therapeutics reports clinical, regulatory, formulation and legal progress

on

Brainomix AI analysis adds support for Endeavor’s IPF therapy

on

BII allocates €8 million in follow-on funding to six startups

on

Wegovy helped 40.4% of children in phase 3 obesity trial reach a non-obese BMI

on

Novartis’s Pelacarsen Fails to Reduce Cardiovascular Risk in Phase 3 Trial

on

Novartis stock drops after Avidity centerpiece fails Phase 3 trial

on

Sandoz targets 100+ biosimilars by 2040 with new $300 million Slovenia facility

on

Inhibrx’s OX40 data provide a rationale—not yet proof—for a cancer-vaccine combination

on